# The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals

> **NCT06419686** · PHASE1 · RECRUITING · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 10 (estimated)

## Conditions studied

- Effect of iv Administration of GIP and Alanine

## Interventions

- **OTHER:** Placebo (saline)
- **DRUG:** GIP
- **DRUG:** Alanine
- **DRUG:** GIP + alanine

## Key facts

- **NCT ID:** NCT06419686
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2024-05
- **Final completion:** 2024-07
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06419686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06419686, "The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06419686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*